IS6134A - Ziprasídón sviflausn - Google Patents

Ziprasídón sviflausn

Info

Publication number
IS6134A
IS6134A IS6134A IS6134A IS6134A IS 6134 A IS6134 A IS 6134A IS 6134 A IS6134 A IS 6134A IS 6134 A IS6134 A IS 6134A IS 6134 A IS6134 A IS 6134A
Authority
IS
Iceland
Prior art keywords
ziprazidone
suspension
ziprazidone suspension
Prior art date
Application number
IS6134A
Other languages
English (en)
Other versions
IS2396B (is
Inventor
Ray Arenson Daniel
Qi Hong
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22472103&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS6134(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of IS6134A publication Critical patent/IS6134A/is
Publication of IS2396B publication Critical patent/IS2396B/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Colloid Chemistry (AREA)
  • Cosmetics (AREA)
  • Dental Preparations (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
IS6134A 1999-05-27 2001-10-30 Síprasídón sviflausn IS2396B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13626899P 1999-05-27 1999-05-27
PCT/IB2000/000593 WO2000072847A1 (en) 1999-05-27 2000-05-08 Ziprasidone suspension

Publications (2)

Publication Number Publication Date
IS6134A true IS6134A (is) 2001-10-30
IS2396B IS2396B (is) 2008-08-15

Family

ID=22472103

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6134A IS2396B (is) 1999-05-27 2001-10-30 Síprasídón sviflausn

Country Status (50)

Country Link
EP (1) EP1181018B1 (is)
JP (1) JP3942827B2 (is)
KR (1) KR100477782B1 (is)
CN (1) CN1196486C (is)
AP (1) AP1409A (is)
AR (1) AR022643A1 (is)
AT (1) ATE234097T1 (is)
AU (1) AU777413B2 (is)
BG (1) BG65367B1 (is)
BR (1) BR0010990A (is)
CA (1) CA2371550C (is)
CO (1) CO5170458A1 (is)
CR (1) CR6506A (is)
CU (1) CU23223B7 (is)
CZ (1) CZ20014230A3 (is)
DE (1) DE60001649T2 (is)
DK (1) DK1181018T3 (is)
DZ (1) DZ3049A1 (is)
EA (1) EA003907B1 (is)
EE (1) EE04704B1 (is)
ES (1) ES2191618T3 (is)
GC (1) GC0000190A (is)
GE (1) GEP20033113B (is)
GT (1) GT200000081A (is)
HK (1) HK1046366B (is)
HN (1) HN2000000071A (is)
HR (1) HRP20010878B1 (is)
HU (1) HUP0201297A3 (is)
IL (2) IL145950A0 (is)
IS (1) IS2396B (is)
MA (1) MA26741A1 (is)
MX (1) MXPA01012124A (is)
MY (1) MY127891A (is)
NO (1) NO320296B1 (is)
NZ (1) NZ514764A (is)
OA (1) OA11946A (is)
PA (1) PA8495801A1 (is)
PE (1) PE20010127A1 (is)
PL (1) PL196867B1 (is)
RS (1) RS50089B (is)
SI (1) SI1181018T1 (is)
SK (1) SK284590B6 (is)
SV (1) SV2001000085A (is)
TN (1) TNSN00112A1 (is)
TR (1) TR200103392T2 (is)
TW (1) TWI263498B (is)
UA (1) UA59491C2 (is)
UY (1) UY26166A1 (is)
WO (1) WO2000072847A1 (is)
ZA (1) ZA200109692B (is)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7175855B1 (en) 1999-05-27 2007-02-13 Pfizer Inc. Ziprasidone suspension
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
ATE526950T1 (de) 1999-10-29 2011-10-15 Euro Celtique Sa Hydrocodon-formulierungen mit gesteuerter freisetzung
EP2263658A1 (en) 2000-10-30 2010-12-22 Euro-Celtique S.A. Controlled release hydrocodone formulations
CN100337630C (zh) * 2002-03-12 2007-09-19 布里斯托尔-迈尔斯斯奎布公司 可口的口服悬浮液及其制备方法
BR0315568A (pt) * 2002-10-25 2005-08-23 Pfizer Prod Inc Formulações de depósito injetáveis
WO2004037224A1 (en) * 2002-10-25 2004-05-06 Pfizer Products Inc. Depot formulations of arylheterocyclic active agents in the form of a suspension
MXPA03009945A (es) 2002-11-05 2007-04-16 Lg Electronics Inc Montaje para montar una pantalla de toque para un monitor con pantalla de cristal liquido.
US7667037B2 (en) 2003-10-24 2010-02-23 Teva Pharmaceutical Industries Ltd. Processes for preparation of ziprasidone
EP1744750A2 (en) 2004-05-06 2007-01-24 Sandoz AG Pharmaceutical composition comprising hydrophobic drug having improved solubility
EP1753400A4 (en) * 2004-06-11 2012-11-28 Reddys Lab Ltd Dr PHARMACEUTICAL FOR ZIPRASIDONE
US20080268034A1 (en) * 2005-01-07 2008-10-30 Girish Karanth Solid Oral Dosage Forms of Ziprasidone Containing Colloidal Silicone Dioxide
KR20080024206A (ko) * 2005-06-20 2008-03-17 엘란 파마 인터내셔널 리미티드 아릴-헤테로시클릭 화합물을 함유하는 나노입자형 조절방출 조성물
US9198862B2 (en) 2005-07-22 2015-12-01 Rubicon Research Private Limited Dispersible tablet composition
CN100391458C (zh) * 2006-02-07 2008-06-04 上海医药工业研究院 齐拉西酮或其盐包合物制备方法
KR20080076667A (ko) * 2007-02-15 2008-08-20 주식회사 중외제약 요변성 약학 조성물
JP4336380B1 (ja) * 2008-11-06 2009-09-30 塩野義製薬株式会社 水懸濁性を向上させた細粒剤
JP6272730B2 (ja) * 2014-05-21 2018-01-31 救急薬品工業株式会社 速溶性フィルム剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4831031A (en) * 1988-01-22 1989-05-16 Pfizer Inc. Aryl piperazinyl-(C2 or C4) alkylene heterocyclic compounds having neuroleptic activity
US5312925A (en) * 1992-09-01 1994-05-17 Pfizer Inc. Monohydrate of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one-hydrochloride
US6150366A (en) * 1998-06-15 2000-11-21 Pfizer Inc. Ziprasidone formulations

Also Published As

Publication number Publication date
BG106153A (bg) 2002-06-28
ES2191618T3 (es) 2003-09-16
TR200103392T2 (tr) 2002-11-21
HK1046366A1 (en) 2003-01-10
TWI263498B (en) 2006-10-11
DK1181018T3 (da) 2003-04-22
GT200000081A (es) 2001-11-16
AP1409A (en) 2005-06-13
CU23223B7 (es) 2007-08-30
HRP20010878B1 (en) 2007-03-31
DE60001649T2 (de) 2003-08-21
RS50089B (sr) 2009-01-22
EP1181018B1 (en) 2003-03-12
NO320296B1 (no) 2005-11-21
GEP20033113B (en) 2003-11-25
IL145950A0 (en) 2002-07-25
UY26166A1 (es) 2000-12-29
NO20015755L (no) 2002-01-23
HRP20010878A2 (en) 2003-06-30
MY127891A (en) 2006-12-29
EA200101131A1 (ru) 2002-04-25
EA003907B1 (ru) 2003-10-30
SK284590B6 (sk) 2005-07-01
JP3942827B2 (ja) 2007-07-11
MXPA01012124A (es) 2002-06-04
CN1352560A (zh) 2002-06-05
NZ514764A (en) 2004-04-30
BR0010990A (pt) 2002-03-05
GC0000190A (en) 2006-03-29
NO20015755D0 (no) 2001-11-26
WO2000072847A1 (en) 2000-12-07
EE04704B1 (et) 2006-10-16
PE20010127A1 (es) 2001-02-06
AP2001002346A0 (en) 2001-12-31
AU777413B2 (en) 2004-10-14
HUP0201297A2 (en) 2002-08-28
UA59491C2 (uk) 2003-09-15
TNSN00112A1 (fr) 2005-11-10
HUP0201297A3 (en) 2005-09-28
ATE234097T1 (de) 2003-03-15
CO5170458A1 (es) 2002-06-27
KR20020048307A (ko) 2002-06-22
CA2371550C (en) 2007-01-02
CA2371550A1 (en) 2000-12-07
CZ20014230A3 (cs) 2002-08-14
SK16782001A3 (sk) 2002-09-10
CR6506A (es) 2004-03-24
PA8495801A1 (es) 2001-12-14
BG65367B1 (bg) 2008-04-30
HN2000000071A (es) 2001-02-02
MA26741A1 (fr) 2004-12-20
EE200100633A (et) 2003-02-17
PL196867B1 (pl) 2008-02-29
KR100477782B1 (ko) 2005-03-21
IS2396B (is) 2008-08-15
PL352826A1 (en) 2003-09-08
DZ3049A1 (fr) 2004-03-27
DE60001649D1 (de) 2003-04-17
EP1181018A1 (en) 2002-02-27
CN1196486C (zh) 2005-04-13
AR022643A1 (es) 2002-09-04
AU4138500A (en) 2000-12-18
YU76701A (sh) 2005-07-19
IL145950A (en) 2007-12-03
SI1181018T1 (en) 2003-06-30
ZA200109692B (en) 2002-11-26
OA11946A (en) 2006-04-13
HK1046366B (zh) 2005-07-29
SV2001000085A (es) 2001-11-08
JP2003500449A (ja) 2003-01-07

Similar Documents

Publication Publication Date Title
DE50012595D1 (de) Aufhängevorrichtung
DE60011764D1 (de) Werkstoffsprüfung
DE10084676T1 (de) Einmallanzettvorrichtung
DE50002834D1 (de) Handstempel
DE60008638D1 (de) Förderbandabstreicher
DE60034061D1 (de) 4-pyrimidinyl-n-acyl-l-phenylanine
DE60008009D1 (de) Einzelradaufhängung
IS6134A (is) Ziprasídón sviflausn
DE50007953D1 (de) Beleuchtungsanordung
DE69924240D1 (de) Ladungsträgerteilchenstrahlvorrichtung
DK1239832T3 (da) Suspension omfattende oxcarbazepin
DE50008613D1 (de) Sicherungsring
DE50016100D1 (de) Gabtriebs
DE60042509D1 (de) Fahrzeugaufhängung
DE50001640D1 (de) Nahfeldoptische untersuchungsvorrichtung
DE60020905D1 (de) Präzisionsstrahlnachführsystem
DE60032195D1 (de) Vorhanggiesser
DE50000794D1 (de) Federelement
DE69934741D1 (de) Aufhängevorrichtung
FI990035A0 (fi) Pyöräripustus
DE60032299D1 (de) Farbdemodulierungsgerät
FI20001519A (fi) Pikakartio
FI991554A (fi) Ripustuslaite
DK199900019U3 (da) Pilk med flere ophængspunkter
FI19992629A (fi) Jousitusjärjestely